BibbInstruments AB (XSAT:BIBB) ROCE % : -49.51% (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BibbInstruments AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BibbInstruments AB's annualized ROCE % for the quarter that ended in Dec. 2024 was -49.51%.

BibbInstruments AB ROCE % Historical Data

The historical data trend for BibbInstruments AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BibbInstruments AB ROCE % Chart

BibbInstruments AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-42.33

-38.53

-42.32

-34.83

-42.61

BibbInstruments AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-39.70	-39.97	-45.62	-28.82	-49.51

BibbInstruments AB ROCE % Calculation

BibbInstruments AB's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-12.697	/	( ( (33.351 - 2.133)	+	(33.728 - 5.349) )	/ 2 )
	=	-12.697	/	( (31.218	+	28.379)	/ 2 )
	=	-12.697	/	29.7985
	=	-42.61 %

BibbInstruments AB's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-14.98	/	( ( (33.75 - 1.614)	+	(33.728 - 5.349) )	/ 2 )
	=	-14.98	/	( ( 32.136	+	28.379 )	/ 2 )
	=	-14.98	/	30.2575
	=	-49.51 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

BibbInstruments AB (XSAT:BIBB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BibbInstruments AB ROCE % Related Terms

Thank you for viewing the detailed overview of BibbInstruments AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

BibbInstruments AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BibbInstruments AB (XSAT:BIBB) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 2, Medicon Village, Lund, SWE, SE-223 81

Website

http://www.bibbinstruments.com

BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.

BibbInstruments AB Headlines

No Headlines